Group 6A: Metastatic Breast Cancer; Exceptional Responders; Predictive Biomarkers

Name: Group 6A: Metastatic Breast Cancer; Exceptional Responders; Predictive Biomarkers
Start: 2023-12-15
End: 2023-12-15

Poster #PO2-06-01: Validity of patient-reported data from long-term survivors of metastatic breast cancer.

Poster #PO1-14-04: A multivariate biomarker to guide antibody-drug conjugate selection and provide insight on response differences across breast cancer subtypes.